Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

The bioconcentration factor shows the concentration of chemical substances in fish as compared to the surrounding water. It ...

Overview Explore the most controversial AI CEOs and leaders shaping innovation, ethics, regulation, and the future direction ...

Assistant Professor of Electrical and Computer Engineering Jason Eshraghian is reimagining how artificial intelligence can ...

It will come as no surprise to anyone when I say that the app industry is a very dynamic one, with things changing by the week or even day, and 2025 was ...

Vulnerabilities in popular AI and ML Python libraries used in Hugging Face models with tens of millions of downloads allow ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

Confer, an open source chatbot, encrypts both prompts and responses so companies and advertisers can’t access user data.

Meta plans to cut around 10% of employees within the division who are working specifically on metaverse-focused products, including virtual-reality headsets and the company's Horizon Worlds social ...

Does living in an unequal society make people unhappy? Not necessarily, reveals the largest study ever conducted on the ...

Palmer Luckey argues China’s strongest weapon is propaganda, highlighting censorship’s social acceptance and its implications ...

The global technology landscape is currently undergoing a seismic shift, driven by the rapid evolution and deployment of AI chipsets. We are moving beyond the theoretical potential of artificial ...